Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of $13.54 billion as of January 9, 2026. Its market cap has decreased by -1.25% in one year.

• Market Cap: 13.54B
• Enterprise Value: 12.90B
• 1-Year Change: -1.25%
• Ranking: #787
• Category: Large-Cap
• Stock Price: $135.79

Market Cap Chart

Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $13.54B, an increase of 10,809.78%. That is a compound annual growth rate of 18.89%.

Market Cap History

Date	Market Cap	% Change
Jan 8, 2026	13.52B	-4.41%
Dec 31, 2025	14.14B	2.32%
Dec 31, 2024	13.82B	6.76%
Dec 29, 2023	12.95B	12.74%
Dec 30, 2022	11.48B	42.11%
Dec 31, 2021	8.08B	-9.78%
Dec 31, 2020	8.96B	-9.54%
Dec 31, 2019	9.90B	52.87%
Dec 31, 2018	6.48B	-5.69%
Dec 29, 2017	6.87B	104.24%
Dec 30, 2016	3.36B	-31.05%
Dec 31, 2015	4.88B	187.17%
Dec 31, 2014	1.70B	169.95%
Dec 31, 2013	629.00M	26.66%
Dec 31, 2012	496.60M	5.73%
Dec 30, 2011	469.70M	12.07%
Dec 31, 2010	419.10M	293.15%
Dec 31, 2009	106.60M	-13.68%
Dec 31, 2008	123.50M	-28.41%
Dec 31, 2007	172.50M	-56.31%
Dec 29, 2006	394.80M	-82.96%
Dec 30, 2005	2.32B	28.86%
Dec 31, 2004	1.80B	-6.54%
Dec 31, 2003	1.92B	37.67%
Dec 31, 2002	1.40B	3.88%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	952.29B
Johnson & Johnson	492.44B
AbbVie	388.97B
UnitedHealth Group	311.59B
AstraZeneca	295.57B
Merck & Co.	274.34B
Novartis AG	272.98B
Novo Nordisk	263.81B